Search results
Having a Cat Can Double Your Chances of Developing Schizophrenia, New Study Says
People via Yahoo News· 3 days agoThis parasite is found in cats living in developed countries across the world and can infect any...
New Study Finds Support for Strange Connection Between Cat Ownership and Schizophrenia
Men's Journal via Yahoo News· 5 days agoAn odd and long-posited connection between cat ownership and schizophrenia symptoms just got a boost...
Early Evidence Supports Ketogenic Diet for Mental Illness
Medscape· 2 days agoA pilot study suggests the ketogenic diet may ease symptoms of schizophrenia and bipolar disorder...
Lewy body dementia – signs, symptoms and treatment
The Telegraph via Yahoo News· 17 hours agoFor years, Des O’Sullivan struggled to pinpoint what felt wrong. When his symptoms started, Des was in his early 50s, a busy publishing consultant whose...
Learn more about mental health | NAMI: National Alliance on Mental Illness
National Alliance on Mental Illness (NAMI)· 28 minutes agoNAMI’s primary role in research is to ensure that people affected by mental illness – both individuals and their families – have access to accurate and timely information regarding ...
Neumora Stock Hits 2024 Low As Side Effects In Rabbits Torpedo Schizophrenia Drug
Investor's Business Daily· 4 days agoNotably, Neumora says it's working on next-generation schizophrenia and antipsychotic treatments...
Cerevel, in ‘major surprise,’ finds success in late-stage Parkinson’s study
BioPharma Dive via Yahoo Finance· 2 days agoBy that time, Cerevel could be owned by AbbVie, which last fall agreed to pay $8.7 billion to...
Heard on the Street: AbbVie’s Bet on a Neuroscience Drug Maker Just Got Better
The Wall Street Journal· 1 day agoNotably, when AbbVie announced the $8.7 billion acquisition of Cerevel back in December, the main...
Childhood Loneliness Predictive of Subsequent Psychosis?
Medscape· 2 days agoSelf-perceived loneliness during childhood is linked to a more than twofold increased risk for...
Nxera Pharma Notes Successful Development Progress of Partnered Schizophrenia Candidate NBI-1117568
Morningstar· 4 days agoNBI-1117568 is an oral, selective muscarinic M4 receptor agonist advancing through Phase 2 clinical development under a multi-program collaboration with Neurocrine BiosciencesSuccessful completion ...